Oxygen CoLab Phase 2: Implementation Phase and overall lessons learning from Co-labs approach

This work goes beyond the COVID-19 response to the long-term strengthening of systems and preparedness for future pandemics. Phase 1 of the Oxygen CoLab will advance the research and development of oxygen concentrators for low-resource settings, whilst also ensuring the business model (Oxygen as a Service) and financial sustainability of those products is being tested and validated. The goal is to contribute to accelerated and sustained access to fit for purpose oxygen concentrators in underserved health centres and hospitals. It will work concurrently across three key workstreams: 1) Accelerate product innovation: Creating an accelerated path to market for fit for purpose oxygen concentrator innovations. 2) Catalyse market traction: Putting oxygen concentrators on the path to sustainable scale in our focus countries, through coaching and funding grantee innovators; evidence-based in-country advocacy; and generating interest and confidence from both country and global stakeholders in innovative financing and alternative business models. 3) Enable a collective response and anticipatory action: Supporting a local and global conversation about oxygen provision, and contributing to a movement for fit for purpose oxygen concentrators.